Mirum Pharmaceuticals: Set Fair For Share Price Momentum - Reversing My Sell Call [Seeking Alpha]
Mirum Pharmaceuticals, Inc. - common stock (MIRM)
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Mirum markets three drugs: LIVMARLI, Cholbam, and Chenodal, with LIVMARLI showing significant growth in treating cholestatic pruritus in ALGS and PFIC. Mirum's 2024 net product sales reached $336.4m, an 88% year-on-year increase, driven by LIVMARLI and the newly acquired bile acid medicines. The likely approval of another IBAT inhibitor, Volixibat in 2027 in PSC / PBC opens up a $500m peak annual revenue market, in my view. The other pipeline asset, MRM-3379, feels more like a "moonshot," but overall, with regard to the investment opportunity for Mirum, I believe the positives outweigh the negatives. Investment Overview Back in October last year in a note for Seeking Alpha I gave Mirum Pharmaceuticals, Inc. NASDAQ: MIRM ) stock a
Read more
Impact Snapshot
Event Time:
MIRM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MIRM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MIRM alerts
High impacting Mirum Pharmaceuticals, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
MIRM
News
- LIVMARLI Now Approved in Japan for ALGS and PFIC [Yahoo! Finance]Yahoo! Finance
- LIVMARLI Now Approved in Japan for ALGS and PFICBusiness Wire
- Mirum's Heavy Dependence on Livmarli for Revenues Remains a Woe [Yahoo! Finance]Yahoo! Finance
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Analyst Estimates: Here's What Brokers Think Of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) After Its Full-Year Report [Yahoo! Finance]Yahoo! Finance
MIRM
Earnings
- 11/12/24 - Beat
MIRM
Sec Filings
- 3/19/25 - Form 4
- 3/18/25 - Form 4
- 3/18/25 - Form 4
- MIRM's page on the SEC website